TENAX THERAPEUTICS, INC. Intangible Assets, Net (Excluding Goodwill)
TENAX THERAPEUTICS, INC. (TENX) had Intangible Assets, Net (Excluding Goodwill) of $0 as of 2016-12-31, per its 10-K filed 2017-03-16.
Discontinued › Balance Sheet › Assets › Assets, Noncurrent › Intangible Asset, Excluding Goodwill, after Accumulated Amortization
us-gaap:IntangibleAssetsNetExcludingGoodwill · last filed 2017-03-16
- 2016-12-31: Intangible Assets, Net (Excluding Goodwill) $0.00.
- 2016-09-30: Intangible Assets, Net (Excluding Goodwill) $22.00M.
- 2016-06-30: Intangible Assets, Net (Excluding Goodwill) $22.00M.
- 2016-03-31: Intangible Assets, Net (Excluding Goodwill) $22.00M.
| Period end | Intangible Assets, Net (Excluding Goodwill) |
|---|---|
| 2016-12-31 | $0.00 10-K · filed 2017-03-16 |
| 2016-09-30 | $22.00M 10-Q · filed 2016-11-09 |
| 2016-06-30 | $22.00M 10-Q · filed 2016-08-09 |
| 2016-03-31 | $22.00M 10-Q · filed 2016-05-10 |
| 2015-12-31 | $22.00M 10-K · filed 2017-03-16 |
| 2015-10-31 | $22.00M 10-Q · filed 2015-12-10 |
| 2015-07-31 | $22.00M 10-Q · filed 2015-09-09 |
| 2015-04-30 | $22.00M 10-KT · filed 2016-03-14 |
| 2015-01-31 | $23.04M 10-Q · filed 2015-03-17 |
| 2014-10-31 | $23.03M 10-Q · filed 2014-12-15 |
| 2014-07-31 | $23.00M 10-Q · filed 2014-09-15 |
| 2014-04-30 | $23.00M 10-KT · filed 2016-03-14 |
| 2014-01-31 | $22.98M 10-Q · filed 2014-03-17 |
| 2013-10-31 | $963.81K 10-Q · filed 2013-12-17 |
| 2013-07-31 | $943.17K 10-Q · filed 2013-09-17 |
| 2013-04-30 | $924.70K 10-K · filed 2014-07-29 |
| 2013-01-31 | $923.40K 10-Q · filed 2013-03-18 |
| 2012-10-31 | $904.50K 10-Q · filed 2012-12-14 |
| 2012-07-31 | $881.32K 10-Q · filed 2012-09-19 |
| 2012-04-30 | $872.97K 10-K · filed 2013-06-26 |
| 2012-01-31 | $863.51K 10-Q · filed 2012-03-15 |
| 2011-10-31 | $831.41K 10-Q · filed 2011-12-15 |
| 2011-07-31 | $746.03K 10-Q · filed 2011-09-19 |
| 2011-04-30 | $699.95K 10-K · filed 2012-07-25 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| PLIANT THERAPEUTICS, INC. (PLRX) | United States | $0.071B | -0.76 |
| PMV Pharmaceuticals, Inc. (PMVP) | United States | $0.071B | -0.95 |
| Yarrow Bioscience, Inc. (YARW) | United States | $0.070B | |
| Lunai Bioworks Inc. (LNAI) | United States | $0.072B | -0.11 |
| Spero Therapeutics, Inc. (SPRO) | United States | $0.073B | 17.41 |
| Connect Biopharma Holdings Ltd (CNTB) | $0.069B | -2.17 | |
| Cingulate Inc. (CING) | United States | $0.073B | -2.64 |
| Aldeyra Therapeutics, Inc. (ALDX) | United States | $0.074B | -5.57 |
| XBiotech Inc. (XBIT) | United States | $0.066B | -1.56 |
| OS Therapies Inc (OSTX) | United States | $0.076B | -2.17 |